tenofovir has been researched along with Esophageal Varices in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Furquim d'Almeida, A; Ho, E; Van Hees, S; Vanwolleghem, T | 1 |
Borghi, M; Cerini, F; Ceriotti, F; Degasperi, E; Facchetti, F; Farina, E; Gentile, C; Lampertico, P; Loglio, A; Monico, S; Perbellini, R; Primignani, M; Tosetti, G; Uceda Renteria, SC; Viganò, M | 1 |
Casazza, G; Colombo, M; de Franchis, R; Facchetti, F; Fraquelli, M; Iavarone, M; Invernizzi, F; Jovani, M; Lampertico, P; Loglio, A; Mangia, G; Primignani, M; Viganò, M | 1 |
1 review(s) available for tenofovir and Esophageal Varices
Article | Year |
---|---|
Clinical management of chronic hepatitis B: A concise overview.
Topics: Aged; Antiviral Agents; Asymptomatic Diseases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Esophageal and Gastric Varices; Hepatic Encephalopathy; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Liver Neoplasms; Male; Seroconversion; Tenofovir; Withholding Treatment | 2022 |
2 other study(ies) available for tenofovir and Esophageal Varices
Article | Year |
---|---|
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Esophageal and Gastric Varices; Female; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tenofovir; Treatment Outcome; Varicose Veins | 2023 |
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Follow-Up Studies; Forecasting; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Italy; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Nucleosides; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Tenofovir | 2015 |